Research and Development

Showing 15 posts of 9573 posts found.

Pharma creates non-profit R&D organisation

September 21, 2012 Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
2ca8123

Transgene appoints Nathalie Adda as chief medical officer

September 21, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene

Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …
itzhak_krinsky

Teva announces appointment of Prof Itzhak Krinsky

September 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva

Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …

Boehringer submits new lung cancer drug

September 20, 2012 Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …
peterson_600

Sandra Peterson joins J&J’s executive committee

September 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson

Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …

RSA announces new Board members

September 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search

Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …

Silence Therapeutics appoints chief medical adviser

September 19, 2012 Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics

Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …
johnson and johnson image

J&J sets up life science centres

September 19, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation

Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …
steven_gillis

Steven Gillis to join Shire Board of directors

September 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis

Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …
EMA building

Salmonson is new chair of CHMP

September 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, MPA, Salmonson

Dr Tomas Salmonson has been elected chair of the Committee for Medicinal Products for Human Use (CHMP) for a three-year …

Circassia appoints Stewart Sharpe as VP Commercial Operations

September 19, 2012 Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe

Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …
screen_shot_2012-09-18_at_15

Two new appointments at Pharmalink Consulting

September 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Webb, Lorcan Flanagan, Pharmalink

Regulatory affairs specialists Pharmalink Consulting has announced two new appointments. Lorcan Flanagan (pictured) joins as European Business Development manager and …
Halaven image

UK at centre of Eisai plans

September 18, 2012 Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven

Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …
Mark Mallon image

Asia-Pacific – pharma’s new centre of gravity?

September 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca

A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …

New data for Pfizer arthritis pill

September 18, 2012 Research and Development, Sales and Marketing JAK, Pfizer, RA, tofacitinib

Pfizer is to release more data for its investigational rheumatoid arthritis (RA) pill tofacitinib which it hopes will demonstrate its …
The Gateway to Local Adoption Series

Latest content